This Article Full Text Full Text (PDF) All Versions of this Article: 51/6/1665    most recent HYPERTENSIONAHA.108.112458v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Zafarmand, M. H. Articles by Bots, M. L. PubMed PubMed Citation Articles by Zafarmand, M. H. Articles by Bots, M. L. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Medline Plus Health Information High Blood Pressure Stroke Related Collections Clinical genetics Cerebrovascular disease/stroke Acute Cerebral Infarction Acute Stroke Syndromes Genetics of Stroke Epidemiology

(Hypertension. 2008;51:1665.)
© 2008 American Heart Association, Inc.

Original Articles

-Adducin Gly460Trp Variant Increases the Risk of Stroke in Hypertensive Dutch Women

Mohammad Hadi Zafarmand; Yvonne T. van der Schouw; Diederick E. Grobbee; Peter W. de Leeuw; Michiel L. Bots

From the Julius Center for Health Sciences and Primary Care (M.H.Z., Y.T.v.d.S., D.E.G., M.L.B.), University Medical Center Utrecht, Utrecht, The Netherlands; the Persian Gulf Health Research Center (M.H.Z.), Bushehr University of Medical Sciences and Health Services, Bushehr, Iran; and the Department of Internal Medicine (P.W.d.L.), University Hospital Maastricht, Maastricht, The Netherlands.

Correspondence to Dr Michiel L. Bots, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Heidelberglaan 100, Str 6.131, 3584 CX Utrecht, Utrecht, The Netherlands. E-mail m.l.bots{at}umcutrecht.nl

The Gly460Trp variant of the -adducin gene has been associated with renal sodium retention and salt-sensitive hypertension. Independent of blood pressure, salt sensitivity has been related to cerebrovascular events. We studied the risk of stroke, coronary heart disease (CHD), and myocardial infarction (MI) associated with the -adducin variant and examined the extent to which this risk is modified by the presence of hypertension. We performed a case-cohort study in a prospective cohort of 15 236 initially healthy Dutch women. We applied a Cox proportional hazards model with an estimation procedure adapted for case-cohort designs to study the relation of the polymorphism and CHD (n=210), MI (n=71), any stroke (n=74), and ischemic stroke (n=49). Subjects with the Gly460Trp variant had a 2.8 times higher risk of stroke (95% confidence intervals [CI] 1.3 to 5.8) under the dominant genetic model, which did not attenuate after adjustment. The same pattern was found under per-allele comparison. Risk of ischemic stroke in the variant allele carriers was 3.9 times higher than in subjects with the common genotype (95% CI 1.7 to 8.6) using dominant inheritance model. The same patterns were found under per-allele comparison. CHD and MI were not related to the variant. The risk of ischemic stroke was more pronounced among women with systolic hypertension (10.9; 95% CI 3.6 to 31.5). The findings in this prospective study in a population based cohort of Dutch women strongly suggest that presence of the -adducin Gly460Trp polymorphism increases the risk of stroke. This risk is particularly elevated in the presence of systolic hypertension.

Key Words: genetics • cerebrovascular disorders • ischemic stroke • coronary artery disease • myocardial infarction • polymorphism • case-cohort studies